Racial differences in the development of de novo donor-specific antibodies and treated antibody-mediated rejection following heart transplantation
The Journal of Heart and Lung Transplantation Nov 09, 2017
Cole RT, et al. - This study aimed at assessing the role of de novo donor-specific antibodies (dnDSA) and antibody-mediated rejection (AMR) in racial disparities in post-transplant outcomes. Findings suggested higher risk for the development of dnDSA and treated AMR among black transplant recipients, which may account for racial disparities in outcomes following heart transplantation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
